Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Other Working Capital Changes (2019 - 2025)

Historic Other Working Capital Changes for Cresco Labs (CRLBF) over the last 7 years, with Q3 2025 value amounting to -$2.3 million.

  • Cresco Labs' Other Working Capital Changes fell 24209.25% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.3 million, marking a year-over-year decrease of 66861.31%. This contributed to the annual value of -$7.9 million for FY2024, which is 10466.01% down from last year.
  • Cresco Labs' Other Working Capital Changes amounted to -$2.3 million in Q3 2025, which was down 24209.25% from -$2.2 million recorded in Q2 2025.
  • In the past 5 years, Cresco Labs' Other Working Capital Changes ranged from a high of $18.6 million in Q3 2022 and a low of -$7.1 million during Q4 2023
  • In the last 5 years, Cresco Labs' Other Working Capital Changes had a median value of $1.6 million in 2024 and averaged $2.6 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 55191.98% in 2022, then plummeted by 24209.25% in 2025.
  • Cresco Labs' Other Working Capital Changes (Quarter) stood at $5.7 million in 2021, then skyrocketed by 89.88% to $10.9 million in 2022, then crashed by 165.13% to -$7.1 million in 2023, then surged by 70.29% to -$2.1 million in 2024, then fell by 10.71% to -$2.3 million in 2025.
  • Its Other Working Capital Changes was -$2.3 million in Q3 2025, compared to -$2.2 million in Q2 2025 and -$2.7 million in Q1 2025.